Your comments on ...

Merck profit dives on weaker sales, restructuring costs

Drug giant Merck posted a 35 percent drop in third-quarter profit on weaker sales and higher restructuring costs as it struggles with the loss of exclusivity on key drugsDrug giant Merck posted Monday a 35 percent drop in third-quarter profit on weaker sales and higher restructuring costs as it struggles with the loss of exclusivity on key drugs. Net income was $1.12 billion in the third quarter, down from $1.73 billion in the year-ago quarter.